Dermira was a biopharmaceutical company focused on medical dermatology, developing and commercializing treatments for chronic skin conditions such as primary axillary hyperhidrosis (Qbrexza / glycopyrronium) and atopic dermatitis (lebrikizumab). - View it on GitHub